Technologies related to NIAID

Title
Prevention or Treatment of Viral Infections by Inhibition of the Histone Methyltransferases EZH1/2
Ref: E-141-2015/0 | Updated: Aug 10, 2015
Recombinant Paramyxoviruses Expressing Optimized Heterologous Antigens
Ref: E-241-2014/0 | Updated: Jun 27, 2017
Adaptor for Suspending a Cryovial Over a Centrifuge Tube
Ref: E-080-2015/0 | Updated: Jul 1, 2015
Live Attenuated Japanese Encephalitis Virus Vaccine
Ref: E-231-2014/0 | Updated: Jul 1, 2015
CXCR4 Reduction Leads to Enhancement of Engraftment of Hematopoietic Stem Cells
Ref: E-173-2014/0 | Updated: Jul 1, 2015
LRRK2 Inhibitors: Novel Treatment for Intestinal Bowel Disorders
Ref: E-070-2014/0 | Updated: Mar 22, 2016
A Novel Virus-Based Expression System
Ref: E-181-2014-0 | Updated: Aug 18, 2015
The Use of Chimeric Antigen Receptor to Control HIV Infection
Ref: E-212-2014/0 | Updated: Sep 9, 2015
A Novel Fusion Protein for Inhibiting HIV Budding
Ref: E-223-2014-0 | Updated: May 10, 2018
Novel Epstein-Barr Virus Vaccines
Ref: E-531-2013/0 | Updated: Dec 17, 2015
Small Molecule Imaging of Fungi by Positron Emission Tomography Scanning
Ref: E-449-2013-0 | Updated: Feb 13, 2017
Multi-specific Chimeric Antigen Receptors Against HIV
Ref: E-170-2013/0 | Updated: Oct 23, 2017
Recombinant Sulfated HIV Envelope Protein and Methods for Making Protein
Ref: E-067-2012/0 | Updated: Apr 15, 2014
Recombinant Stabilized Prefusion Protein of Respiratory Syncytial Virus for Use as a Subunit Vaccine
Ref: E-081-2013-0 | Updated: Jun 22, 2018
Bispecific Antibodies to Target Latent HIV-1 Infection
Ref: E-071-2012/0 | Updated: Jan 6, 2014
Recombinant NIE Antigen from Strongyloides stercoralis
Ref: E-081-2012/0 | Updated: Nov 13, 2013
Monoclonal Antibodies That Recognize the Human Type I Interferon Receptor and Block Interferon Signaling
Ref: E-527-2013/0 | Updated: Aug 22, 2013
Safer Attenuated Virus Vaccines with Missing or Diminished Latency of Infection
Ref: E-217-2004/0 | Updated: Jul 9, 2013
Live Attenuated RSV Vaccines Based on Codon-Pair Deoptimization
Ref: E-080-2013-0 | Updated: Jun 6, 2013
Novel Vaccine for Prevention and Treatment of Chlamydia Infection
Ref: E-133-2012/0 | Updated: Aug 11, 2015
Transmission-Blocking Malaria Vaccine
Ref: E-222-2012-0 | Updated: May 16, 2018
Glucocorticoid-induced TNFR Family-Related Receptor Ligand (GITRL) Antibodies for Diagnosis and Treatment of Immune System Disorders
Ref: E-229-2003/2 | Updated: Nov 16, 2012
Antimalarial Inhibitors that Target the Plasmodial Surface Anion Channel (PSAC) Protein and Development of the PSAC Protein as Vaccine Targets
Ref: E-145-2011-0 | Updated: May 22, 2018
A Method to Expand a Population of Regulatory T Cells Optimal for the Treatment of Autoimmune Diseases
Ref: E-279-2011/0 | Updated: Sep 9, 2015
Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin as an Influenza Vaccine
Ref: E-293-2011/0 | Updated: Apr 11, 2016
Salen-Manganese Compounds for Therapy of Viral Infections
Ref: E-281-2011/0 | Updated: Apr 11, 2016
Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most HIV-1 Strains
Ref: E-253-2011/0 | Updated: Jun 18, 2014
Treatment of Tuberculosis — Adjuvant Therapies to Increase the Efficiency of Antibiotics
Ref: E-189-2011-0 | Updated: May 7, 2018
Protease Deficient Bacillus anthracis with Improved Recombinant Protein Yield Capabilities
Ref: E-202-2011/0 | Updated: Feb 25, 2015
Humanized Monoclonal Antibodies Efficient for Neutralization of Tick-Borne Encephalitis Virus (TBEV)
Ref: E-231-2011/0 | Updated: Sep 29, 2011
Rapid Molecular Assays for Specific Detection and Quantitation of Loa Loa Microfilaremia
Ref: E-014-2011/0 | Updated: May 3, 2016
Diagnostic Assays and Methods of Use for Detection of Filarial Infection
Ref: E-281-2010-0 | Updated: May 6, 2018
Monoclonal Antibodies Against Poliovirus
Ref: E-076-2011/0 | Updated: Mar 9, 2015
Multivalent Vaccines for Rabies Virus and Filoviruses
Ref: E-032-2011-0 | Updated: May 7, 2018
Mouse IL-12p40 Expressing Cell Line
Ref: E-247-2010/0 | Updated: May 20, 2011
Improved Standard for Immune System Recovery Assay
Ref: E-067-2011/0 | Updated: Nov 3, 2017
Mouse Anti-Mouse CXCL9 (Mig) Monoclonal Antibodies
Ref: E-198-2009/0 | Updated: Oct 12, 2010
Prevention and Treatment of Herpes Virus Infection by Inhibition of the JMJD2 Family of Histone Demethylases
Ref: E-184-2010/0 | Updated: Mar 18, 2015
Full-Length Infectious cDNA Clones of Tick Borne Flavivirus
Ref: E-281-1998/0 | Updated: Sep 28, 2010
Method of Producing Immortalized Primary Human Keratinocytes for HPV Investigation, Testing of Therapeutics, and Skin Graft Generation
Ref: E-055-2009/0 | Updated: Sep 21, 2015
The Use of Recombinant Cholera Toxin-B for the Treatment of Inflammatory Bowel Disease
Ref: E-263-1999/0 | Updated: Jul 16, 2010
Novel Antigen for Use as Vaccine Against Nematode Infection
Ref: E-084-2010/0 | Updated: Jul 12, 2010
Sound Attenuation Canopy for Reducing Noise Transmitted Through Suspended Ceilings
Ref: E-102-2010/0 | Updated: Jul 31, 2012
Methods to Increase Stability of Recombinant Vaccinia-Vectored Vaccines and Increase Expression of a Foreign Gene Inserted in Such Vaccines
Ref: E-018-2010/0 | Updated: Sep 10, 2015
T-Cell-Specific Gfi-1 Knockout Mouse
Ref: E-242-2009-0 | Updated: May 16, 2018
Biological/Research Material for HIV Vaccine Research
Ref: E-258-2009/0 | Updated: Sep 10, 2015
Biological/Research Material for H1N1 Influenza Virus Vaccine Research
Ref: E-260-2009/0 | Updated: Sep 10, 2015
Bactericidal Peptides from Avian Leukocyte Ribonuclease A-2
Ref: E-281-2006/0 | Updated: Sep 18, 2009
Monoclonal Antibodies That React With the Capsule of Bacillus anthracis
Ref: E-125-2008/0 | Updated: Aug 31, 2009
Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses
Ref: E-078-2009/0 | Updated: Aug 31, 2012
Recombinant Vaccines Based on Poxvirus Vectors
Ref: E-552-1982/2 | Updated: Aug 18, 2015
Methods for Treating or Ameliorating Fibrosis by Inhibiting the Interaction between IL-21 Receptor (IL-21R) and IL-21
Ref: E-250-2005-0 | Updated: May 16, 2018
A Unique Infectious Hepatitis C Virus Clone, Strain HC-TN (genotype 1a)
Ref: E-249-2007/0 | Updated: Jul 14, 2009
A Novel System for Producing Infectious Hepatitis C Virus (HCV) Virions and Development of a Novel Reporter System for Studying HCV Entry
Ref: E-005-2009/0 | Updated: Jun 16, 2010
Enhanced Immune Response Against Influenza Virus by Priming with a DNA-based Vaccine
Ref: E-341-2008/0 | Updated: Jun 8, 2009
Interactive Venn Diagram Software Designed for Microarray Analysis
Ref: E-189-2009/0 | Updated: Jun 1, 2009
Axenically-Produced Coxiella burnetii and Methods for Producing Axenic Coxiella burnetii
Ref: E-114-2009/0 | Updated: Jun 1, 2009
Novel Method of Treating Cancer Using Ixolaris
Ref: E-148-2009/0 | Updated: Jun 16, 2010
Cell Based Immunotherapy
Ref: E-312-2008/0 | Updated: Sep 22, 2015
Microwave-Assisted Freeze Substitution of Biological and Biomedical Samples
Ref: E-238-2008/2 | Updated: Jul 12, 2010
Mouse Monoclonal Antibodies to MAD1, a Human Spindle Assembly Checkpoint Protein for Maintaining Chromosomal Segregation
Ref: E-119-2003/0 | Updated: Jan 19, 2016
Humanized Monoclonal Antibodies that Specifically Bind Japanese Encephalitis Virus (JEV) and Their Use
Ref: E-142-2008/0 | Updated: Jun 14, 2010
Sialostatin Mediation Controls Blood-feeding Success of the Tick Ixodes scapularis
Ref: E-289-2007/0 | Updated: Feb 2, 2009
Use of Mono-Amine Oxidase Inhibitors to Prevent Herpes Virus Infections and Reactivation from Latency
Ref: E-275-2008/0 | Updated: Oct 18, 2010
A Varicella-Zoster Virus Mutant that is Markedly Impaired for Latent Infection Available for the Development of Shingles Vaccines and Diagnostics
Ref: E-029-2007-0 | Updated: Dec 1, 2008
Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses
Ref: E-120-2001/0 | Updated: Feb 28, 2011
Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4
Ref: E-089-2002/1 | Updated: May 6, 2016
Monoclonal Antibodies Against Orthopoxviruses
Ref: E-145-2004/3 | Updated: Oct 1, 2008
Development of Antigenic Chimeric St. Louis Encephalitis Virus/Dengue Virus Type Four Recombinant Viruses (SLEV/DEN4) as Vaccine Candidates for the Prevention of Disease Caused by SLEV
Ref: E-240-2007/0 | Updated: Feb 28, 2011
Monoclonal Antibodies Against Dengue and Other Viruses With Deletion in Fc Region
Ref: E-159-2007/3 | Updated: Feb 28, 2011
Live Attenuated Virus Vaccines for La Crosse Virus and Other Bunyaviridae
Ref: E-158-2007/3 | Updated: Jul 1, 2014
Generation of Wild-Type Dengue Viruses for Use in Rhesus Monkey Infection Studies
Ref: E-042-2008/0 | Updated: Sep 12, 2012
Live Attenuated Vaccine to Prevent Disease Caused by West Nile Virus
Ref: E-357-2001-1 | Updated: Sep 10, 2015
Development of Dengue Virus Type 3 Vaccine Candidates
Ref: E-139-2006-0 | Updated: May 9, 2016
Live Attenuated Virus Vaccines for La Crosse Virus and Other Bunyaviridae
Ref: E-158-2007-3 | Updated: Jul 1, 2014
Murine Monoclonal Antibodies Effective To Treat Respiratory Syncytial Virus
Ref: B-056-1994/1 | Updated: Feb 14, 2013
Human Neutralizing Monoclonal Antibodies to Respiratory Syncytial Virus and Human Neutralizing Antibodies to Respiratory Syncytial Virus
Ref: E-032-1993/1 | Updated: Sep 1, 2008
Monoclonal Antibodies that Neutralize B. anthracis Protective Antigen (PA), Lethal Factor (LF) and Edema Factor (EF)
Ref: E-146-2004/0 | Updated: Sep 1, 2008
Neutralizing Monoclonal Antibodies to Respiratory Syncytial Virus
Ref: E-001-1996/0 | Updated: Sep 1, 2008
Respiratory Syncytial Virus (RSV) Vaccines Based on Promoter-Proximate Attenuation
Ref: E-225-2000/0 | Updated: Sep 1, 2008
A Rapid Ultrasensitive Assay for Detecting Prions Based on the Seeded Polymerization of Recombinant Normal Prion Protein (rPrP-sen)
Ref: E-109-2007-1 | Updated: May 7, 2018
A Novel Treatment for Malarial Infections
Ref: E-202-2008-0 | Updated: Apr 21, 2016
A Prophylactic and Therapeutic for Preventing and Treating Tularemia by Rapid Activation of Host Cells and Antigen Recognition
Ref: E-095-2008-0 | Updated: May 16, 2018
Full-Length cDNA Clone Representing the Consensus Sequence of the RNA Genome of a Human Norovirus (strain MD145-12) That Encodes Biologically Active Proteins
Ref: E-212-2003-0 | Updated: May 16, 2018
Enzymatically-Active RNA-Dependent RNA Polymerase From a Human Norovirus (Calicivirus)
Ref: E-283-2003-0 | Updated: May 16, 2018
Construction of an Infectious Full-Length cDNA Clone of the Porcine Enteric Calicivirus RNA Genome
Ref: E-214-2003-0 | Updated: May 16, 2018
Construction of Recombinant Baculoviruses Carrying the Gene Encoding the Major Capsid Protein, VP1, From Calicivirus Strains (Including Norovirus Strains Toronto, Hawaii, Desert Shield, Snow Mountain, and MD145-12)
Ref: E-198-2003-0 | Updated: May 16, 2018
The Use of an Inducible Plasmid Vector Encoding for Active TGF-beta for the Treatment of Autoimmune Diseases
Ref: E-096-2000/0 | Updated: May 1, 2008
Muramyl Dipeptide as a Therapeutic Agent for Inflammation
Ref: E-110-2006/0 | Updated: Jun 16, 2010
HPV Virus-Like Particles for Delivery of Gene-Based Vaccines
Ref: E-077-2008/0 | Updated: Mar 14, 2018
HPV Virus-Like Particles for Delivery of Gene-Based Vaccines
Ref: E-077-2008-0 | Updated: Mar 14, 2018
Influenza Vaccines, Therapeutics, and Monoclonal Antibodies
Ref: E-116-2006/0 | Updated: Oct 21, 2009
Assay for Identification of Influenza-Neutralizing Antibodies
Ref: E-323-2007/0 | Updated: Apr 1, 2008
Codon Optimized Genes for Subunit Vaccines
Ref: E-326-2006/1 | Updated: Apr 1, 2008
PSM Peptides as Vaccine Targets Against Methicillin-Resistant Staphylococcus aureus
Ref: E-239-2007-3 | Updated: May 7, 2018
HIV Monoclonal Antibodies
Ref: E-109-2008-0 | Updated: May 18, 2018
Ribosomal Protein S3 (RPS3), an Essential Component of NF-kappaB is a Novel and Selective Drug Target
Ref: E-162-2007/0 | Updated: Feb 1, 2008
Chlamydia Vaccine
Ref: E-031-2006/0 | Updated: Sep 15, 2015
Collagen-Induced Platelet Aggregation Inhibitor from Mosquito Salivary Glands
Ref: E-172-2007/0 | Updated: Jul 31, 2012
The Use of alpha-4 beta-7 integrin Inhibitors to Inhibit HIV Transmission and Infection
Ref: E-055-2007/0 | Updated: Feb 28, 2014

Pages

Subscribe to Technologies related to NIAID